Proposal on global pharma pricing GMF ZURICH, April 4th, 2005

1
Proposal on global pharma pricing GMF ZURICH,
April 4th, 2005

• Annie CHICOYE
• AREMIS Consultants C.E.O.

2
A few introductory remarks

• What should be the reward ?
• The specificities for pharma market
• The future portfolio

3
What should be the reward ?
Top 10 companies In each sector Financial
information 2000/2001
Gross Revenue / sales (Source Innovation
report LIR, 2002 )
4
What should be the reward ?
Top 10 companies In each sector Financial
information 2000/2001
Net Revenue / assets (Source Innovation report
LIR, 2002 )
5
What should be the reward ?
Top 10 companies In each sector Financial
information 2000/2001
RD / Sales (Source Innovation report LIR,
2002 )
6
The specificities RD costs and outputs
(Source Innovation report LIR, 2002 )
7
The specificities success rate
(Source Innovation report LIR, 2002 )
8
The specificities time to market registration
(Source Innovation report LIR, 2002 )
9
The specificities time to market
reimbursement and price fixing
(Source Innovation report LIR, 2002 )
10
The future porftfolio
(Source Innovation report LIR, 2002 )
11
The future portfolio
(Source Innovation report LIR, 2002 )
12
The future portfolio

• Blockbusters  the end of the golden era  ?
• New blockbusters still more difficult to
  achieve for safety and costs concerns
• Targeting population lower volumes, different
  promotion targets, higher prices, combined
  health care goods provision